ABT-546 |
ABT-546 : Antagonist of EDNRA
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EDNRA |
|
|
Antagonist
may be used up to 10 µM
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
EDNRB: Ki = 13000 nM; Clean GPCR scan
CEREP panel of receptors (at 10 µM): closest hits: EDNRB = 56% ...
Potency Cellular
In Vitro
EDNRA
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1016/s0014-2999(98)00891-7
In Vivo Validations
Rat
Dose: 5 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
1.6 h
Systemic clearance:
1.5 l/h*kg
Volume of Distribution at Steady-State:
0.56 - 3.7 l/kg
DOI Reference: 10.1016/s0014-2999(98)00891-7
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
2.5 h
Cmax:
1.69 μg/ml
Tmax:
1.3 h
Bioavailability:
47.7%
DOI Reference: 10.1016/s0014-2999(98)00891-7
Dog
Dose: 5 mg/Kg
Route of delivery:
Oral
Plasma half life:
3.3 h
Cmax:
1.97 μg/ml
Bioavailability:
19.9 %
DOI Reference: 10.1016/s0014-2999(98)00891-7
Monkey (Cynomolgus)
Dose: 5 mg/Kg
Route of delivery:
Oral
Plasma half life:
1 h
Cmax:
1.1 μg/ml
Bioavailability:
18.1 %
DOI Reference: 10.1016/s0014-2999(98)00891-7
Negative Control Compounds
Chemical Information
| Molecular Formula | C30H48N2O6 |
| SMILEs | CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC |
| InChI | InChI=1S/C30H48N2O6/c1-7-10-13-31(14-11-8-2)26(33)19-32-18-22(21-15-24(36-6)28-25(16-21)37-20-38-28)27(29(34)35)23(32)17-30(4,5)12-9-3/h15-16,22-23,27H,7-14,17-20H2,1-6H3,(H,34,35)/t22-,23+,27-/m1/s1 |
| Molecular weight | 532.35 Da |
| AlogP | 5.5377 |
| HBond acceptors | 8 |
| HBond donors | 1 |
| Atoms | 86 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.